Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Jensen Thomas, Chief Executive Officer. Officer active across 1 company, notably Allarity Therapeutics, Inc.. Aggregated, 2 disclosures have been recorded. Activity tracked since 22 January 2025. The latest transaction was filed on 28 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Jensen Thomas is the CEO of Allarity Therapeutics, Inc. He oversees the company's operations and is responsible for the overall strategy. His leadership is essential for growth and innovation in the biotechnology sector.